Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN--A Randomized, Phase III Study

✍ Scribed by Satoh, T.; Xu, R.-H.; Chung, H. C.; Sun, G.-P.; Doi, T.; Xu, J.-M.; Tsuji, A.; Omuro, Y.; Li, J.; Wang, J.-W.; Miwa, H.; Qin, S.-K.; Chung, I.-J.; Yeh, K.-H.; Feng, J.-F.; Mukaiyama, A.; Kobayashi, M.; Ohtsu, A.; Bang, Y.-J.

• Book ID: 125497481
• Publisher: American Society of Clinical Oncology
• Year: 2014
• Tongue: English
• Weight: 335 KB
• Volume: 32
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2013.53.6136